对马泽伊等人的回复。从放射学角度提出的一些担忧。对“黄等人。转移性胃癌转化手术与前方手术加姑息化疗或单纯前方手术的疗效比较。2022年，，555”的评论。
Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on "Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555".
作者信息
Kou Hao-Wei, Hsu Jun-Te
机构信息
Department of General Surgery, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
出版信息
J Pers Med. 2022 Jun 30;12(7):1069. doi: 10.3390/jpm12071069.
Abstract
We thank the authors for their interest in our article "Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone" [...].
摘要
我们感谢作者对我们的文章《转移性胃癌转化手术与先行手术加姑息化疗或单纯先行手术的疗效比较》的关注。[...]
相似文献
1
Reply to Mazzei et al. Some Concerns from a Radiological Point of View. Comment on "Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555".
J Pers Med. 2022 Jun 30;12(7):1069. doi: 10.3390/jpm12071069.
2
Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555.
J Pers Med. 2022 Jun 29;12(7):1061. doi: 10.3390/jpm12071061.
3
Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.
J Pers Med. 2022 Apr 1;12(4):555. doi: 10.3390/jpm12040555.
4
Reply to Graziosi et al. Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on "Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553".
J Pers Med. 2023 Jun 13;13(6):988. doi: 10.3390/jpm13060988.
5
Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. 2022, , 410".
J Pers Med. 2022 May 25;12(6):861. doi: 10.3390/jpm12060861.
6
Rationale in the Use of Adjuvant Chemotherapy in pT3N0M0 Gastric Cancer Resected Patients. Comment on Chen et al. Prognostic Factors and the Role of Adjuvant Chemotherapy in Pathological Node-Negative T3 Gastric Cancer. 2023, , 553.
J Pers Med. 2023 Jun 9;13(6):974. doi: 10.3390/jpm13060974.
7
Reply to Su et al. Comment on "Matsumoto et al. Remimazolam's Effects on Postoperative Nausea and Vomiting Are Similar to Those of Propofol after Laparoscopic Gynecological Surgery: A Randomized Controlled Trial. 2023, , 5402".
J Clin Med. 2024 Feb 9;13(4):1002. doi: 10.3390/jcm13041002.
8
Reply to Brea et al. Comment on "Levitt et al. Approach to Decompensated Right Heart Failure in the Acute Setting. 2024, , 869".
J Clin Med. 2024 Jun 29;13(13):3849. doi: 10.3390/jcm13133849.
9
Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women. 2022, , 1176".
J Clin Med. 2022 May 30;11(11):3086. doi: 10.3390/jcm11113086.
10
Reply to Mattei et al. Jacob Disease, Osteochondroma of the Coronoid Process, Coronoid Process Hyperplasia or Langenbeck Disease: The Big Jumble. Comment on "Raccampo et al. Jacob's Disease: Case Series, Extensive Literature Review and Classification Proposal. 2023, , 938".
J Clin Med. 2023 Aug 4;12(15):5118. doi: 10.3390/jcm12155118.
本文引用的文献
1
Some Concerns from a Radiological Point of View. Comment on Huang et al. Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone. 2022, , 555.
J Pers Med. 2022 Jun 29;12(7):1061. doi: 10.3390/jpm12071061.
2
Outcomes of Conversion Surgery for Metastatic Gastric Cancer Compared with In-Front Surgery Plus Palliative Chemotherapy or In-Front Surgery Alone.
J Pers Med. 2022 Apr 1;12(4):555. doi: 10.3390/jpm12040555.
3
Imaging of Gastric Carcinomatosis.
J Clin Med. 2021 Nov 14;10(22):5294. doi: 10.3390/jcm10225294.
4
CT imaging of peritoneal carcinomatosis with surgical correlation: a pictorial review.
Insights Imaging. 2021 Nov 12;12(1):168. doi: 10.1186/s13244-021-01110-6.
5
Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Gastric Cancer. 2020 Mar;23(2):319-327. doi: 10.1007/s10120-019-00994-0. Epub 2019 Jul 26.
6
Conversion Surgery for Gastric Cancer with Peritoneal Metastasis Based on the Diagnosis of Second-Look Staging Laparoscopy.
J Gastrointest Surg. 2019 Sep;23(9):1758-1766. doi: 10.1007/s11605-018-3983-7. Epub 2018 Sep 27.
7
Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2016 Sep;27(suppl 5):v38-v49. doi: 10.1093/annonc/mdw350.
8
Evaluation of computed tomography in patients with peritoneal carcinomatosis.
Cancer. 1993 Sep 1;72(5):1631-6. doi: 10.1002/1097-0142(19930901)72:5<1631::aid-cncr2820720523>3.0.co;2-i.
Zotero 插件